TLR4 and Anxiety: Based on the above research results, Rezaeian et al. suggested that oral berberine (100 mg/kg) modulated neuroinflammation and reduced anxiety behavior via suppressing the activation of TLR4 and NF-κB in METH-addicted rats (Rezaeian et al., 2020).